|
PIGP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.219200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.640070E-04 |
| Normal-vs-Stage2 |
6.596100E-03 |
| Normal-vs-Stage3 |
1.632550E-01 |
| Normal-vs-Stage4 |
5.156200E-01 |
| Stage1-vs-Stage2 |
3.409800E-01 |
| Stage1-vs-Stage3 |
9.496500E-02 |
| Stage1-vs-Stage4 |
2.811600E-02 |
| Stage2-vs-Stage3 |
5.288000E-02 |
| Stage2-vs-Stage4 |
3.166200E-02 |
| Stage3-vs-Stage4 |
5.624600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.603600E-04 |
| Normal-vs-AfricanAmerican |
6.602400E-01 |
| Normal-vs-Asian |
5.361400E-01 |
| Caucasian-vs-AfricanAmerican |
9.246200E-02 |
| Caucasian-vs-Asian |
2.412800E-01 |
| AfricanAmerican-vs-Asian |
5.431400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.658400E-03 |
| Normal-vs-Female |
3.360800E-03 |
| Male-vs-Female |
8.194200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.688600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.787300E-04 |
| Normal-vs-Age(61-80Yrs) |
8.061900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.504160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.452300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.295840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.483590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.372000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.836800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.770200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.045580E-02 |
| Normal-vs-Grade 2 |
8.88370000007299E-07 |
| Normal-vs-Grade 3 |
3.282200E-02 |
| Normal-vs-Grade 4 |
1.508040E-01 |
| Grade 1-vs-Grade 2 |
6.867600E-01 |
| Grade 1-vs-Grade 3 |
1.466420E-01 |
| Grade 1-vs-Grade 4 |
1.303430E-03 |
| Grade 2-vs-Grade 3 |
3.218500E-03 |
| Grade 2-vs-Grade 4 |
1.79860000004695E-07 |
| Grade 3-vs-Grade 4 |
2.360200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.13789999645064E-09 |
| Normal-vs-ccB subtype |
8.378400E-01 |
| ccA subtype-vs-ccB subtype |
1.51229999634239E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.957770E-02 |
| Normal-vs-N1 |
5.940200E-01 |
| N0-vs-N1 |
1.888990E-01 |
|
|
